Symbol: |
PKD2
|
Description: |
polycystic kidney disease 2 (autosomal dominant) [Source:HGNC Symbol;Acc:9009]
|
Location: |
Chr4:88928820-88998929[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:254
Gene |
Compound |
Gen_sig |
Exp_pattern |
PKD2 |
2-(2-(Dimethylamino)ethylamino)naphthazarin |
0.001 |
Up |
PKD2 |
Nitrotolazoline |
0.006 |
Down |
PKD2 |
NSC 660809 |
0.008 |
Up |
PKD2 |
NSC 665277 |
0.029 |
Up |
PKD2 |
NSC 668261 |
0.029 |
Up |
PKD2 |
NSC 669308 |
0.005 |
Down |
PKD2 |
NSC 669450 |
0.017 |
Down |
PKD2 |
NSC 669678 |
0.04 |
Up |
PKD2 |
Ethanamine, N,N-dimethyl-2-[4-(1,1-dimethylethyl)- 1-[(4-methylphenyl)methyl]cyclohexyloxy]-, (trans)-, (E)-2-butenedioate (fumaric acid) (1:1) |
0.04 |
Up |
PKD2 |
NSC 670314 |
0.024 |
Up |
PKD2 |
NSC 670316 |
0.046 |
Up |
PKD2 |
NSC 671002 |
0.004 |
Down |
PKD2 |
Benzoic acid, 2,4-dichloro-, 6-acetyl-1,2,3,4-tetrahydro- 4-oxo-1,3-diphenyl-2-thioxothieno[2,3-d]pyrimidin-5-yl ester |
0.001 |
Down |
PKD2 |
NSC 671314 |
0.013 |
Up |
PKD2 |
NSC 671898 |
0.001 |
Down |
Expression pattern: Sensitivity / Resistance
Total:17 Current:5
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:27
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:10
Total:1 Current:1
[First] [Prev] [Next] [Last]
|